OA07586A - Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation. - Google Patents
Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation.Info
- Publication number
- OA07586A OA07586A OA58156A OA58156A OA07586A OA 07586 A OA07586 A OA 07586A OA 58156 A OA58156 A OA 58156A OA 58156 A OA58156 A OA 58156A OA 07586 A OA07586 A OA 07586A
- Authority
- OA
- OAPI
- Prior art keywords
- quinolizine
- benzo
- dihydro
- oxo
- dimethyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- -1 alkylaminoalkyl ester salts Chemical class 0.000 abstract 2
- 150000001263 acyl chlorides Chemical class 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/441,245 US4472405A (en) | 1982-11-12 | 1982-11-12 | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
OA07586A true OA07586A (fr) | 1985-03-31 |
Family
ID=23752110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA58156A OA07586A (fr) | 1982-11-12 | 1983-11-10 | Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation. |
Country Status (22)
Country | Link |
---|---|
US (1) | US4472405A (fi) |
EP (1) | EP0109284B1 (fi) |
JP (1) | JPH0826017B2 (fi) |
KR (1) | KR890000864B1 (fi) |
AT (1) | ATE39926T1 (fi) |
AU (1) | AU568319B2 (fi) |
CA (2) | CA1254568A (fi) |
CS (1) | CS390391A3 (fi) |
DE (1) | DE3378912D1 (fi) |
EG (1) | EG16492A (fi) |
ES (1) | ES8504727A1 (fi) |
FI (1) | FI73213C (fi) |
GR (1) | GR79402B (fi) |
IE (1) | IE56232B1 (fi) |
IL (1) | IL70198A (fi) |
IN (1) | IN161391B (fi) |
MX (1) | MX7314E (fi) |
NO (1) | NO160782C (fi) |
NZ (1) | NZ206233A (fi) |
OA (1) | OA07586A (fi) |
PT (1) | PT77649B (fi) |
ZA (1) | ZA838436B (fi) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3519926A1 (de) * | 1985-06-04 | 1986-12-04 | Bayer Ag | Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel |
CA1302413C (en) * | 1986-01-22 | 1992-06-02 | Bruce E. Williams | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid |
US4898945A (en) * | 1986-01-22 | 1990-02-06 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid |
GB9827865D0 (en) * | 1998-12-18 | 1999-02-10 | Woodcock Fiona | Medicament |
DE10312346A1 (de) * | 2003-03-20 | 2004-09-30 | Bayer Healthcare Ag | Kontrolliertes Freisetzungssystem |
DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
DE102006010643A1 (de) | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
DE102007026550A1 (de) * | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
DE102007055341A1 (de) | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
AU2011315555B2 (en) | 2010-10-12 | 2016-03-10 | Elanco Animal Health Gmbh | Non-starch based soft chewables |
US10543170B2 (en) | 2012-12-19 | 2020-01-28 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
MD4291C1 (ro) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Preparat medicamentos pentru tratamentul otitelor |
CN114727622A (zh) * | 2019-09-06 | 2022-07-08 | 礼蓝美国公司 | 适口颗粒状兽用药组合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793524A (fr) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
ZA728444B (en) * | 1971-12-30 | 1973-10-31 | Riker Laboratories Inc | Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof |
JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
JPS5655388A (en) | 1979-10-11 | 1981-05-15 | Otsuka Pharmaceut Co Ltd | Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation |
US4301289A (en) * | 1980-02-19 | 1981-11-17 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
JPS59155381A (ja) * | 1983-02-22 | 1984-09-04 | Kyorin Pharmaceut Co Ltd | ベンゾキノリジンカルボン酸誘導体及びその製造法 |
-
1982
- 1982-11-12 US US06/441,245 patent/US4472405A/en not_active Expired - Lifetime
-
1983
- 1983-10-27 CA CA000439826A patent/CA1254568A/en not_active Expired
- 1983-11-09 NO NO834093A patent/NO160782C/no unknown
- 1983-11-10 OA OA58156A patent/OA07586A/xx unknown
- 1983-11-10 ES ES527163A patent/ES8504727A1/es not_active Expired
- 1983-11-11 PT PT77649A patent/PT77649B/pt not_active IP Right Cessation
- 1983-11-11 ZA ZA838436A patent/ZA838436B/xx unknown
- 1983-11-11 NZ NZ206233A patent/NZ206233A/en unknown
- 1983-11-11 JP JP58212306A patent/JPH0826017B2/ja not_active Expired - Lifetime
- 1983-11-11 MX MX8310883U patent/MX7314E/es unknown
- 1983-11-11 AT AT83306908T patent/ATE39926T1/de not_active IP Right Cessation
- 1983-11-11 IN IN1382/CAL/83A patent/IN161391B/en unknown
- 1983-11-11 IL IL70198A patent/IL70198A/xx not_active IP Right Cessation
- 1983-11-11 EP EP83306908A patent/EP0109284B1/en not_active Expired
- 1983-11-11 DE DE8383306908T patent/DE3378912D1/de not_active Expired
- 1983-11-11 GR GR72947A patent/GR79402B/el unknown
- 1983-11-11 AU AU21181/83A patent/AU568319B2/en not_active Ceased
- 1983-11-11 FI FI834147A patent/FI73213C/fi not_active IP Right Cessation
- 1983-11-11 IE IE2639/83A patent/IE56232B1/en not_active IP Right Cessation
- 1983-11-12 EG EG70383A patent/EG16492A/xx active
- 1983-11-12 KR KR1019830005376A patent/KR890000864B1/ko not_active IP Right Cessation
-
1988
- 1988-08-05 CA CA000574069A patent/CA1280755C/en not_active Expired - Fee Related
-
1991
- 1991-12-19 CS CS913903A patent/CS390391A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
ATE39926T1 (de) | 1989-01-15 |
EP0109284B1 (en) | 1989-01-11 |
FI834147A (fi) | 1984-05-13 |
IE56232B1 (en) | 1991-05-22 |
IL70198A0 (en) | 1984-02-29 |
KR840006659A (ko) | 1984-12-01 |
JPH0826017B2 (ja) | 1996-03-13 |
JPS59112969A (ja) | 1984-06-29 |
US4472405A (en) | 1984-09-18 |
PT77649B (en) | 1986-03-19 |
CA1280755C (en) | 1991-02-26 |
NO834093L (no) | 1984-05-14 |
IN161391B (fi) | 1987-11-28 |
EG16492A (en) | 1994-11-30 |
FI73213B (fi) | 1987-05-29 |
NO160782C (no) | 1989-05-31 |
PT77649A (en) | 1983-12-01 |
CS390391A3 (en) | 1992-09-16 |
MX7314E (es) | 1988-05-11 |
CA1254568A (en) | 1989-05-23 |
FI73213C (fi) | 1987-09-10 |
DE3378912D1 (de) | 1989-02-16 |
IL70198A (en) | 1988-11-15 |
ZA838436B (en) | 1985-06-26 |
NZ206233A (en) | 1986-10-08 |
IE832639L (en) | 1984-05-12 |
FI834147A0 (fi) | 1983-11-11 |
KR890000864B1 (ko) | 1989-04-11 |
EP0109284A1 (en) | 1984-05-23 |
ES527163A0 (es) | 1985-05-01 |
ES8504727A1 (es) | 1985-05-01 |
AU2118183A (en) | 1984-05-17 |
NO160782B (no) | 1989-02-20 |
GR79402B (fi) | 1984-10-22 |
AU568319B2 (en) | 1987-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA07586A (fr) | Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation. | |
IE782070L (en) | Azabicyclo (3.2.0) hept-2-ene carboxylic acid derivatives | |
JPS5569586A (en) | 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid | |
FR2392964A1 (fr) | Nouveaux derives de cyclopropane, leur procede de preparation et leur application comme insecticides | |
BE865124A (fr) | Procede de preparation d'esters d'acides butane-dicarboxyliques | |
SE8904104D0 (sv) | Stereospecifikt foerfarande foer framstaellning av furo/3,4-c/pyridinenantiomerer, de saa erhaallna foereningarna och terapeutiska kompositioner daerav | |
ES8106516A1 (es) | Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos | |
BE864481A (fr) | Esters m-phenoxybenzyliques d'acides (difluoro-2,2 benzodioxole-1,3)-5- alpha-alkylacetiques utiles comme insecticides et acaricides et procede de leur preparation | |
FR2427339A1 (fr) | Nouveaux derives optiquement actifs d'oxazaphosphorine et leur procede de preparation | |
SE8005663L (sv) | Forfarande for framstellning av en farmaceutiskt aktiv komposition | |
FR2396001A1 (fr) | Derives a-acetyleniques et a-vinyliques d'amino-acides utiles comme medicaments et leur procede de preparation | |
OA06792A (fr) | Procédé de préparation de dérivés esters d'acides cyclopropane-carboxylique. | |
BE880332A (fr) | Procede de preparation de derives esters d'acide apovincaminique | |
SE8301687D0 (sv) | 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav | |
OA06793A (fr) | Procédé de préparation de dérivés esters d'acides cyclopropane-carboxyliques. | |
ES2031833T3 (es) | Procedimiento para la obtencion de nuevos arilmetoxitiofenoderivados nitrogenados. | |
BE864113A (fr) | Procede de preparation d'esters d'acides diphenylalcanoiques | |
DK550183A (da) | 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden | |
DE3461464D1 (en) | Derivatives of d-2-(6-methoxy-2-naphthyl)-propionic acid having therapeutical activity, process for their preparation and pharmaceutical compositions containing them | |
FR2373549A1 (fr) | Procede de transformation de 3-methylenecephalosporines en 3-heterothiomethylcephalosporines | |
GB2120250A (en) | Enantiomers of 2,3,3a,4,5,6- hexahydro-1H-indolo(3,2,1- de)-[1,5-naphthyridine] | |
FI892587A (fi) | Foerfarande foer framstaellning av gangliosidderivat. | |
BE863842A (fr) | Procede de preparation de nouveaux derives d'acide indolyglyoxylique utiles comme medicaments | |
FR2531434B1 (fr) | Procede de preparation d'esters boriques d'esters d'acides gras de glycerol | |
FR2532314B1 (fr) | Nouveau procede de preparation de derives de l'acide 3-quinoleine carboxylique, nouveaux derives halogenes de l'acide 3-quinoleine carboxylique, leur application comme medicaments, les compositions pharmaceutiques les renfermant et les intermediaires nouveaux obtenus |